DeNovoTherapies LLC
Biotech · Private
An oral epigenetic therapeutic combining decitabine and tetrahydrouridine (THU-Dec) for sickle cell disease
- Grants
- $1.9M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · A Novel, Non-Cytotoxic, Epigenetic Therapeutic for Sickle Cell Disease | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A Novel Non Cytotoxic Epigenetic Therapeutic for Sickle Cell Disease | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel, Non-Cytotoxic, Epigenetic Therapeutic for Sickle Cell Disease | $750,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel, Non-Cytotoxic, Epigenetic Therapeutic for Sickle Cell Disease | $750,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1411 | Complex Computation, LLC | — | — |
| 1412 | Mirai Bio | — | — |
| 1413 | Abcombi Biosciences Inc | — | — |
| 1414 | DeNovoTherapies LLC | — | — |
| 1415 | Op-T-Mune, Inc | — | — |
| 1416 | COGENTIS THERAPEUTICS INC | — | — |
| 1417 | Omega Biosystems Incorporated | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.